LBH589 (panobinostat)
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for LBH589 (panobinostat), covering 2012-11-27 to 2017-05-17. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I Study of LBH589 (Panobinostat) in Combination With External Beam Radiotherapy for the Treatment of Prostate Cancer, Esophageal Cancer and Head and Neck Cancer [Phase 1]